Overview

Conference: October 24-25, 2024

In a market that is constantly adapting and adjusting to the needs of the healthcare field, real-world evidence (RWE) is becoming increasingly important for regulatory and reimbursement decision-making. Historically used for post-market safety monitoring, RWE is now integrated throughout the product development lifecycle, and has led to the real-time analysis of data to better understand and gain insights on disease, approaches to treatment, and how to substantiate coverage decisions.

DIA’s Real-World Evidence Conference will explore new, innovative applications of RWE, and deliver cutting-edge insights to leverage this knowledge to advance healthcare decision-making.

While we develop our 2024 agenda, please take a moment to review the last year final agenda

Participant Testimonials

DIA RWE is the best RWE-related event I've attended - it has compelling speakers, strong education opportunities, and a great collective of attendees. – Nicholaas Honig, JD, Senior Regulatory Counsel, Aetion

Great meeting. Very strong content. Was a really efficient way for me to catch up on RWD/E happenings over the past year! – Meredith Zozus, PhD, Professor; Division Chief and Director, Clinical Research Informatics, University of Texas Health Science Center

Featured

Want to learn more about Real-World Evidence Conference? You've come to the right site!

Program Committee

David Martin, MD, MPH Vice President, Global Head RWE
Moderna, United States
Jaclyn Bosco, PhD, MPH, FISPE Vice President and Global Head of Epidemiology
IQVIA, United States
John Concato, MD, MPH, MS Associate Director for Real-World Evidence Analytics, OMP, CDER
FDA, United States
Diane Gubernot, DrPH, MPH Epidemiologist
US FDA, United States
Rachele Hendricks-Sturrup, DrSc, MA, MSc Research Director, Real-World Evidence
Duke-Robert J. Margolis, MD, Center for Health Policy, United States
Camille Jackson Director, Regulatory Policy; Legal and Regulatory
Flatiron Health , United States
Charles Lee, MBA, MS Executive Regulatory Science Director
AstraZeneca, United States
Alexander Liede, PhD, MSc Senior Director, Global Epidemiology
Abbvie, Ireland
Sarah Martin, PhD, MS Senior Director - Global Regulatory Policy (Oncology)
Eli Lilly & Co., United States
Brittany McKelvey, PhD Director, Regualtory Affairs
Friends of Cancer Research, United States
Keri Monda, PhD, MS Executive Director, Center for Observational Research
Amgen, United States